EN
HI
Summary
As of 2 Nov, 2026, Piramal Pharma stock price is ₹213.96. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Piramal Pharma has traded between ₹132.30 and ₹220.36.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 120 @ ₹213.96.
Piramal Pharma has an upper circuit limit of ₹286.69 and a lower circuit limit of ₹191.13. The total value traded stands at ₹0.00, and the delivery percentage for the day is 21.35%.
The stock is currently traded with a market lot size of 1. Piramal Pharma also offers a dividend yield of 0%.
Piramal Pharma Share Price Chart
Piramal Pharma Share Key Metrics
Volume
0.00
Market Cap
28520.14 CR
LTQ@LTP
120@213.96
ATP
0
Var Margin
19.66 %
Circuit Range
191.13-286.69
Delivery %
21.35 %
Value
0.00
ASM/GSM
No
Market Lot
1
Piramal Pharma Fundamentals
P/E Ratio
0
P/B Ratio
3.91
Div. Yield
0
Sector P/E
39.15
Sector P/B
3.23
Sec. Div. Yield
0.54
Piramal Pharma Resistance and Support
Pivot 231.99
Resistance
First Resistance
238.34
Second Resistance
245.89
Third Resistance
252.24
Support
First Support
224.44
Second Support
218.09
Third Support
210.54
Piramal Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 229.95 | 238.91 | 3.53% | 240 | 225.82 |
| Thu Oct 29 2026 | 231.72 | 230.77 | -0.87% | 239.53 | 225.63 |
| Wed Oct 28 2026 | 214.1 | 232.8 | 17.15% | 235.63 | 209.03 |
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-27 | Quarterly Results |
| 2026-07-29 | Quarterly Results |
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
HDFC Mutual Fund sold 2,69,92,907 shares (2.027% stake) in Piramal Pharma on 28 Oct 2026 via open market transactions. Post this sale, the fund's shareholding in the company decreased from 7.015% to 4.988%.
Oct 31 2026 11:18:00
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Piramal Pharma reported Q2 FY27 cons. revenue of Rs.2,617 crore, up 28% YoY, and a net profit of Rs.5 crore, recovering from a YoY loss. The company upgraded its FY27 revenue growth outlook to 19-20%, driven by robust order inflows and execution in its CDMO business.
Oct 27 2026 21:04:04
Read More
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Maneesh Sharma | Company Secretary and Compliance Officer |
Piramal Pharma Similar Stocks
Narayana Hrudayalaya Ltd.
1862.00
147.50 (8.60%)
Global Health Ltd.
1478.00
178.30 (13.72%)
Dr. Lal Pathlabs Ltd.
1895.00
-16.70 (0.87%)
Sai Life Sciences Ltd.
1584.90
89.20 (5.96%)
Wockhardt Ltd.
2088.70
165.80 (8.62%)
Acutaas Chemicals Ltd.
3169.00
-807.70 (20.31%)
Krishna Institute of Medical Sciences Ltd
762.00
59.50 (8.47%)
Rubicon Research Ltd.
1763.00
203.70 (13.06%)
Neuland Laboratories Ltd.
22640.00
3360.00 (17.43%)
Granules India Ltd.
849.80
12.45 (1.49%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 213.96 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 3.91. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 28520.14 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 220.36 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PPLPHARMA
